Tumour Biomarker and Plasma Time Course Data from Abigail, A Phase II Study of 1st-Line Bevacizumab + Chemotherapy in Advanced Non-Squamous Non-Small-Cell Lung Cancer (NS-NSCLC)
Reck, M., Gorbunova, V.A., Juhasz, E., Szima, B., Orlov, S., Yu, C., Pallaud, C., Scherer, S.J., Archer, V., Mok, T.S.K.Volume:
23
Journal:
Annals of Oncology
DOI:
10.1016/s0923-7534(20)33798-4
Date:
September, 2012
File:
PDF, 60 KB
2012